OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

To reveal more filter options, please select whether you would like to review Active or Closed projects:

Clear
Investigator: Andrew Blackwell

1 Projects | 1 Researchers | $200,000 Invested

2008

Cambridge Cognition Ltd.

Andrew Blackwell, PhD

Prototype development for the Guided Neuropsychological Evaluation (G:NE - pronounced 'genie') system for the early detection and differential diagnosis of Alzheimer's disease

  • Funding Amount: $200,000
  • Organization Type: Biotechnology/For Profit
  • Program: Biomarkers
  • Status: Closed